Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Oncology ReviewsOpen Access

Non-coding RNAs as novel biomarkers and therapeutic targets in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

VBVeronica BarbiSMSara De MartinoAAAurora Aiello

Discussion

Loading...

Member takes

Overview

This review highlights the role of non-coding RNAs in breast cancer heterogeneity and their potential as biomarkers and therapeutic targets.

Key Points

  • Non-coding RNAs play a critical role in breast cancer biology, influencing tumor initiation, progression, and treatment resistance.
  • Distinct expression profiles of non-coding RNAs across breast cancer subtypes underscore their potential as effective biomarkers and therapeutic targets.
  • This review explores the multifaceted functional roles of non-coding RNAs in breast cancer and their implications for personalized medicine.
  • Understanding the complex mechanisms behind non-coding RNAs can lead to innovative strategies for better managing breast cancer patients.

Cite This Study

Barbi et al. (2025) studied this question.

synapsesocial.com/papers/68bb42212b87ece8dc958a2fhttps://doi.org/10.3389/or.2025.1621144
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes2021 · 282 citations
  2. 2The MicroRNA Spectrum in 12 Body Fluids2010 · 2,763 citations
  3. 3Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma2011 · 3,317 citations
  4. 4Disorders and roles of tsRNA, snoRNA, snRNA and piRNA in cancer2022 · 80 citations